Investigación Biomédica y Sanitaria
MEDONLINE
University of Cologne
Colonia, AlemaniaUniversity of Cologne-ko ikertzaileekin lankidetzan egindako argitalpenak (21)
2020
-
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 628-639
2017
-
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2869-2878
2016
-
Infection-related and -unrelated malignancies, HIV and the aging population
HIV Medicine, Vol. 17, Núm. 8, pp. 590-600
2015
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
2014
-
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
Infection, Vol. 42, Núm. 4, pp. 757-762
-
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study
BMC Nephrology, Vol. 15, Núm. 1
-
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe
PLoS ONE, Vol. 9, Núm. 1
2013
2012
-
Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients
AIDS, Vol. 26, Núm. 15, pp. 1917-1926
-
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: The EuroSIDA study
PLoS ONE, Vol. 7, Núm. 7
2011
-
A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy
Journal of Infectious Diseases, Vol. 204, Núm. 5, pp. 741-752
-
European guidelines on the clinical management of HIV-1 tropism testing
The Lancet Infectious Diseases, Vol. 11, Núm. 5, pp. 394-407
-
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
AIDS Reviews, Vol. 13, Núm. 2, pp. 77-108
2010
-
Dialysis and renal transplantation in HIV-infected patients: A European survey
Journal of Acquired Immune Deficiency Syndromes, Vol. 55, Núm. 5, pp. 582-589
2009
-
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal
Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151
-
When and how to use maraviroc in HIV-infected patients
AIDS, Vol. 23, Núm. 18, pp. 2377-2385
2008
-
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA
AIDS, Vol. 22, Núm. 3, pp. 367-376
-
Optimal use of maraviroc in clinical practice
AIDS, Vol. 22, Núm. 17, pp. 2231-2240